Oral Oncology
Volume 36, Issue 1 , Pages 27-31, January 2000

Craniofacial osseous and chondromatous sarcomas in British Columbia—a review of 34 cases

  • M. Gorsky

      Affiliations

    • Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Ramat Aviv, Israel
  • ,
  • J.B. Epstein

      Affiliations

    • Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Ramat Aviv, Israel
    • British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada
    • Department of Dentistry, Vancouver Hospital Health Sciences Centre and University of British Columbia, Vancouver, British Columbia, Canada
    • University of Washington, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6. Tel.: +1-604-877-6000 ext. 2356; fax: +1-604-872-4596

Received 4 March 1999; accepted 23 March 1999.

Abstract 

Head and neck sarcomas are very rare diseases. The aim of this study was to assess the prevalence and presentation of hard tissue sarcomas in the head and neck and jaws. A search of the British Columbia Tumor Registry identified 34 craniofacial hard tissue sarcomas (11 chondrosarcomas, 23 osteosarcomas) over a period of 29 years. A male predominance (1.8:1) and a mean age of 40.4 years at diagnosis were seen. Of the 23 patients with osteosarcoma, one-third survived for 5 years and 12 (52%) died within a mean of 20 months. Of the 11 patients with chondrosarcoma, 45% survived for 5 years and two (18%) of the patients died within a mean of 6 months. In nine of the osteosarcoma patients (39%) the jaws were involved, and in six of those cases (67%) there was mandibular involvement. Swelling was the first sign in all jaw patients, with a mean age of 41.1 years at diagnosis and a male predominance with a ratio of 8:1. Three of the eight male patients with osteosarcoma of the jaw (38%) died within a mean of less than 1 year. Improved prognosis is related to early recognition and diagnosis to allow for adequate surgical resection. The benefit of a combination of surgery with irradiation or chemotherapy continues to be investigated.

Keywords:  Craniofacial osseous sarcoma, Chondromatous sarcoma, Head and neck

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(99)00042-1

Oral Oncology
Volume 36, Issue 1 , Pages 27-31, January 2000